ID   AK1D1_RAT               Reviewed;         326 AA.
AC   P31210;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   02-OCT-2024, entry version 149.
DE   RecName: Full=Aldo-keto reductase family 1 member D1;
DE            EC=1.3.1.3 {ECO:0000250|UniProtKB:P51857};
DE   AltName: Full=3-oxo-5-beta-steroid 4-dehydrogenase;
DE   AltName: Full=Delta(4)-3-ketosteroid 5-beta-reductase;
DE   AltName: Full=Delta(4)-3-oxosteroid 5-beta-reductase;
GN   Name=Akr1d1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1710579; DOI=10.1016/0014-5793(91)80591-p;
RA   Onishi Y., Noshiro M., Shimosato T., Okuda K.;
RT   "Molecular cloning and sequence analysis of cDNA encoding delta 4-3-
RT   ketosteroid 5 beta-reductase of rat liver.";
RL   FEBS Lett. 283:215-218(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=1789929; DOI=10.1515/bchm3.1991.372.2.1039;
RA   Onishi Y., Noshiro M., Shimosato T., Okuda K.;
RT   "Delta 4-3-Oxosteroid 5 beta-reductase. Structure and function.";
RL   Biol. Chem. Hoppe-Seyler 372:1039-1049(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=8550030; DOI=10.1002/hep.510230116;
RA   Zhu Y., Fillenwarth M.J., Crabb D., Lumeng L., Lin R.C.;
RT   "Identification of the 37-kd rat liver protein that forms an acetaldehyde
RT   adduct in vivo as delta 4-3-ketosteroid 5 beta-reductase.";
RL   Hepatology 23:115-122(1996).
CC   -!- FUNCTION: Catalyzes the stereospecific NADPH-dependent reduction of the
CC       C4-C5 double bond of bile acid intermediates and steroid hormones
CC       carrying a delta(4)-3-one structure to yield an A/B cis-ring junction.
CC       This cis-configuration is crucial for bile acid biosynthesis and plays
CC       important roles in steroid metabolism. Capable of reducing a broad
CC       range of delta-(4)-3-ketosteroids from C18 (such as, 17beta-
CC       hydroxyestr-4-en-3-one) to C27 (such as, 7alpha-hydroxycholest-4-en-3-
CC       one). {ECO:0000250|UniProtKB:P51857}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5beta-cholestan-3-one + NADP(+) = cholest-4-en-3-one + H(+) +
CC         NADPH; Xref=Rhea:RHEA:11524, ChEBI:CHEBI:15378, ChEBI:CHEBI:16074,
CC         ChEBI:CHEBI:16175, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.3;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:11526;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4,5beta-dihydrocortisone + NADP(+) = cortisone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:14037, ChEBI:CHEBI:15378, ChEBI:CHEBI:16962,
CC         ChEBI:CHEBI:18093, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.3;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:14039;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cortisol + H(+) + NADPH = 5beta-dihydrocortisol + NADP(+);
CC         Xref=Rhea:RHEA:46644, ChEBI:CHEBI:732, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17650, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46645;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=corticosterone + H(+) + NADPH = 5beta-dihydrocorticosterone +
CC         NADP(+); Xref=Rhea:RHEA:46664, ChEBI:CHEBI:15378, ChEBI:CHEBI:16827,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:86381;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46665;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7alpha,12alpha-dihydroxycholest-4-en-3-one + H(+) + NADPH =
CC         7alpha,12alpha-dihydroxy-5beta-cholestan-3-one + NADP(+);
CC         Xref=Rhea:RHEA:46632, ChEBI:CHEBI:2288, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28477, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46633;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7alpha-hydroxycholest-4-en-3-one + H(+) + NADPH = 7alpha-
CC         hydroxy-5beta-cholestan-3-one + NADP(+); Xref=Rhea:RHEA:46640,
CC         ChEBI:CHEBI:2290, ChEBI:CHEBI:15378, ChEBI:CHEBI:17899,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46641;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=epitestosterone + H(+) + NADPH = 5beta-dihydroepitestosterone
CC         + NADP(+); Xref=Rhea:RHEA:46652, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:42534, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:86377; Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46653;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androst-4-ene-3,17-dione + H(+) + NADPH = 5beta-androstane-
CC         3,17-dione + NADP(+); Xref=Rhea:RHEA:46656, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16422, ChEBI:CHEBI:16985, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46657;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + progesterone = 5beta-pregnan-3,20-dione +
CC         NADP(+); Xref=Rhea:RHEA:46660, ChEBI:CHEBI:15378, ChEBI:CHEBI:17026,
CC         ChEBI:CHEBI:30154, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46661;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=21-hydroxyprogesterone + H(+) + NADPH = 5beta-
CC         dihydrodeoxycorticosterone + NADP(+); Xref=Rhea:RHEA:46668,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16973, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:86384;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46669;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=aldosterone + H(+) + NADPH = 5beta-dihydroaldosterone +
CC         NADP(+); Xref=Rhea:RHEA:46672, ChEBI:CHEBI:15378, ChEBI:CHEBI:27584,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:86389;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46673;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-hydroxyandrosta-1,4-dien-3-one + H(+) + NADPH = 17beta-
CC         hydroxy-5beta-androst-1-en-3-one + NADP(+); Xref=Rhea:RHEA:47076,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:34584, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:87331;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47077;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-hydroxyestr-4-en-3-one + H(+) + NADPH = 17beta-hydroxy-
CC         5beta-estran-3-one + NADP(+); Xref=Rhea:RHEA:47080, ChEBI:CHEBI:7466,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:87333; Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47081;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5beta-dihydrotestosterone + NADP(+) = H(+) + NADPH +
CC         testosterone; Xref=Rhea:RHEA:46636, ChEBI:CHEBI:2150,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17347, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.3;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46637;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androst-4-ene-3,11,17-trione + H(+) + NADPH = 17beta-
CC         hydroxyandrost-4-ene-3,11-dione + NADP(+); Xref=Rhea:RHEA:53484,
CC         ChEBI:CHEBI:2495, ChEBI:CHEBI:15378, ChEBI:CHEBI:34133,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53485;
CC         Evidence={ECO:0000250|UniProtKB:P51857};
CC   -!- ACTIVITY REGULATION: Subject to inhibition by high substrate
CC       concentrations. Inhibited by testosterone concentrations above 10 uM.
CC       Inhibited by the primary and secondary bile acids chenodeoxycholic acid
CC       and ursodeoxycholic acid. {ECO:0000250|UniProtKB:P51857}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P51857}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D17309; BAA04131.1; -; mRNA.
DR   EMBL; S80431; AAB35916.2; -; mRNA.
DR   PIR; S15835; S15835.
DR   RefSeq; NP_620239.1; NM_138884.1.
DR   AlphaFoldDB; P31210; -.
DR   SMR; P31210; -.
DR   STRING; 10116.ENSRNOP00000017675; -.
DR   ChEMBL; CHEMBL5760; -.
DR   iPTMnet; P31210; -.
DR   PhosphoSitePlus; P31210; -.
DR   jPOST; P31210; -.
DR   PaxDb; 10116-ENSRNOP00000017675; -.
DR   GeneID; 192242; -.
DR   KEGG; rno:192242; -.
DR   UCSC; RGD:620752; rat.
DR   AGR; RGD:620752; -.
DR   CTD; 6718; -.
DR   RGD; 620752; Akr1d1.
DR   eggNOG; KOG1577; Eukaryota.
DR   InParanoid; P31210; -.
DR   OrthoDB; 890110at2759; -.
DR   PhylomeDB; P31210; -.
DR   BioCyc; MetaCyc:MONOMER-14304; -.
DR   Reactome; R-RNO-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-RNO-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-RNO-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   SABIO-RK; P31210; -.
DR   PRO; PR:P31210; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0047568; F:3-oxo-5-beta-steroid 4-dehydrogenase activity; IDA:MGI.
DR   GO; GO:0004032; F:aldose reductase (NADPH) activity; IBA:GO_Central.
DR   GO; GO:0047787; F:Delta4-3-oxosteroid 5beta-reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047086; F:ketosteroid monooxygenase activity; IBA:GO_Central.
DR   GO; GO:0016229; F:steroid dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0008209; P:androgen metabolic process; ISO:RGD.
DR   GO; GO:0006699; P:bile acid biosynthetic process; ISO:RGD.
DR   GO; GO:0030573; P:bile acid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0008207; P:C21-steroid hormone metabolic process; ISO:RGD.
DR   GO; GO:0006707; P:cholesterol catabolic process; ISO:RGD.
DR   GO; GO:0007586; P:digestion; ISO:RGD.
DR   CDD; cd19109; AKR_AKR1D1-3; 1.
DR   Gene3D; 3.20.20.100; NADP-dependent oxidoreductase domain; 1.
DR   InterPro; IPR020471; AKR.
DR   InterPro; IPR044483; AKR1D1.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   InterPro; IPR036812; NADP_OxRdtase_dom_sf.
DR   PANTHER; PTHR11732:SF211; ALDO-KETO REDUCTASE FAMILY 1 MEMBER D1; 1.
DR   PANTHER; PTHR11732; ALDO/KETO REDUCTASE; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; NAD(P)-linked oxidoreductase; 1.
DR   PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   Bile acid catabolism; Cytoplasm; Direct protein sequencing;
KW   Lipid degradation; Lipid metabolism; NADP; Oxidoreductase;
KW   Reference proteome; Steroid metabolism.
FT   CHAIN           1..326
FT                   /note="Aldo-keto reductase family 1 member D1"
FT                   /id="PRO_0000124672"
FT   ACT_SITE        57
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         22..26
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         26
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         52
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         57
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         88
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         119
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         131
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         168..169
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         192
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         219..224
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         230
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
FT   BINDING         273..283
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P51857"
SQ   SEQUENCE   326 AA;  37378 MW;  32D8266BFA62CE99 CRC64;
     MNLSTANHHI PLNDGNSIPI IGLGTYSDPR PVPGKTFIAV KTAIDEGYRH IDGAYVYRNE
     HEVGEAIREK VAEGKVKREE IFYCGKLWST DHDPEMVRPA LERTLQTLKL DYIDLYIIEM
     PMAFKPGEEF YPKDENGRVI YHKSNLCATW EALEACKDAG LVKSLGVSNF NRRQLEVILN
     KPGLKYKPVT NQVECHPYFT QTKLLEVSAS SMTSFIVAYS PLGTCRNPLW VNVSSPPLLK
     DELLTSLGKK YNKTQAQIVL RFDIQRGLVV IPKSTTPERI KENFQIFDFS LTKEEMKDIE
     ALNKNVRFVE MLMWSDHPEY PFHDEY
//
